27.01.2012 • News

Eastman Chemical Buys Solutia for $3.38 Billion

Eastman Chemical said it would buy specialty chemical maker Solutia for about $3.38 billion in cash and stock to expand in Asia Pacific. Solutia stockholders would receive $22 in cash and 0.12 shares of Eastman for each share held. The per-share value of $27.65 is a 42% premium to Solutia's Thursday close of $19.51 on the New York Stock Exchange.

Including debt, the deal is valued at about $4.7 billion, Eastman said. The deal, which is expected to add to earnings immediately, will close in mid-2012.

Eastman expects the deal to help it save about $100 million annually by the end of 2013. The company will finance the deal with cash on hand and debt.

Eastman Chemical was formed in 1994, when Eastman Kodak spun off its chemicals business to help pay down debt. While Eastman Chemical has grown steadily, Kodak filed for bankruptcy earlier this month.

Citi and Barclays Capital are acting as financial advisers to Eastman, while Deutsche Bank Securities and Moelis & Co LLC advised Solutia.

 

Company

Eastman Chemical Company

200 South Wilcox Drive
37662 Kingsport

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read